Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/27/2025

Timing of Testosterone Level Measurements for Patients on Testosterone Injections

Initial Monitoring After Starting Therapy

  • Testosterone levels should be tested 2-3 months after treatment initiation and/or after any dose change, with the first follow-up visit occurring at 1-2 months to assess efficacy of treatment, according to the American Gastroenterological Association 1, 2
  • Once stable levels are confirmed on a given dose, monitoring every 6-12 months is typically sufficient, as recommended by the American Gastroenterological Association 1, 2
  • The first follow-up visit should occur at 1-2 months to assess efficacy of treatment, with consideration of dose escalation if clinical response is inadequate, as suggested by the American Medical Association 4

Pharmacokinetics of Testosterone Injections

  • After intramuscular injection of testosterone cypionate, peak serum testosterone levels occur 2-5 days post-injection, with a return to baseline by 10-14 days after injection, according to the American Medical Association 5
  • Injectable testosterone creates fluctuating serum testosterone levels with peaks and valleys between injections, as noted by the American Gastroenterological Association 1

Proper Timing for Accurate Assessment

  • For standard testosterone cypionate or enanthate injections, measure levels midway between injections, targeting a mid-normal value, as recommended by the American Gastroenterological Association 1, 2, 3
  • When interpreting blood test results, clinicians must consider the interval since the most recent injection, according to the American Medical Association 4

Target Levels and Dose Adjustments

  • The target for testosterone levels when measured midway between injections should be in the mid-normal range, as recommended by the American Gastroenterological Association 1, 2
  • If clinical response is suboptimal and testosterone levels are in the low-normal range, the testosterone dosage should be increased, as suggested by the American Medical Association 4
  • If the hematocrit rises above the reference range, consider temporarily withholding testosterone therapy, reducing the dosage, or performing phlebotomy, according to the American Medical Association 4, 5